疫苗|癌症疫苗不靠谱？实际上，这是一部屡败屡战的奋斗史( 五 )
[5] Small, E.J., et al.,Placebo-controlled phase III trial ofimmunologic therapy with sipuleucel-T (APC8015) in patients with metastatic,asymptomatic hormone refractory prostate cancer. J Clin Oncol, 2006. 24(19): p. 3089-94.
[6] DeVita, V.T., Jr., The Provenge decision. Nat Clin PractOncol, 2007. 4(7): p. 381.
[7] Thornton, M., Black Wednesday at the FDA. The WallStreet Journal 2007.
[8] Real-World Study of 6,000+ Medicare Patients with Advanced ProstateCancer Shows Adding PROVENGE (sipuleucel-T) to Treatment Regimen Reduced Riskof Death by 45%. Businesswire, 2020.
[9] Robbins, R., A cancer researcher races to find a cure —for his own incurable cancer. STAT, 2016.
[10] Sun, C. and S. Xu, Advances in personalized neoantigen vaccinesfor cancer immunotherapy. Biosci Trends, 2020. 14(5): p. 349-353.
[11] Sahin, U., et al., Personalized RNA mutanome vaccines mobilizepoly-specific therapeutic immunity against cancer. Nature, 2017. 547(7662): p. 222-226.
[12] Hu, Z., et al., Personal neoantigen vaccines inducepersistent memory T cell responses and epitope spreading in patients withmelanoma. Nat Med, 2021. 27(3):p. 515-525.
[13] Cheever, M.A., etal., The prioritization of cancerantigens: a national cancer institute pilot project for the acceleration oftranslational research. Clin Cancer Res, 2009. 15(17): p. 5323-37.
[14] Gulley, J.L., et al.,Phase III Trial of PROSTVAC inAsymptomatic or Minimally Symptomatic Metastatic Castration-Resistant ProstateCancer. J Clin Oncol, 2019. 37(13):p. 1051-1061.
[15] Zaidi, N., Can Personalized Neoantigens Raise the TCell Bar? Cell, 2020. 183(2): p.301-302.
[16] McGranahan, N., etal., Clonal neoantigens elicit T cellimmunoreactivity and sensitivity to immune checkpoint blockade. Science,2016. 351(6280): p. 1463-9.
[17] AIVITA Biomedical's Phase 2 Glioblastoma Trial Shows ImprovedProgression Free Survival.
[18] Saxena, M., et al., Therapeutic cancer vaccines. Nat RevCancer, 2021.
[19] Ott, P.A., et al., A Phase Ib Trial of Personalized NeoantigenTherapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell LungCancer, or Bladder Cancer. Cell, 2020. 183(2):p. 347-362 e24.
[20] Lopez JS, e.a., A phase Ib study to evaluate RO7198457, anindividualized neoantigen specific immunotherapy (iNeST), in combination withatezolizumab in patients with locally advanced or metastatic solid tumors. .Cancer Res., 2020. 80:CT301. .
[21] Burris HA, e.a., A phase I multicenter study to assess thesafety, tolerability, and immunogenicity of mRNA-4157 alone in patients withresected solid tumors and in combination with pembrolizumab in patients withunresectable solid tumors. 2019.
[22] Ma, C., et al., A clinical microchip for evaluation ofsingle immune cells reveals high functional heterogeneity in phenotypicallysimilar T cells. Nat Med, 2011. 17(6):p. 738-43.
[23] Trimble, C.L., etal., Safety, efficacy, and immunogenicityof VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: arandomised, double-blind, placebo-controlled phase 2b trial. Lancet, 2015. 386(10008): p. 2078-2088.
[24] Kimura, T., et al., MUC1 vaccine for individuals with advancedadenoma of the colon: a cancer immunoprevention feasibility study. CancerPrev Res (Phila), 2013. 6(1): p.18-26.
[25] Schumacher, T.N., W.Scheper, and P. Kvistborg, CancerNeoantigens. Annu Rev Immunol, 2019. 37:p. 173-200.
推荐阅读
- mrna疫苗|【揭秘】mRNA疫苗成功上市，是偶然还是必然？
- 癌症|经常生气和得癌症有关系吗？今天给了个准话儿，爱生气的人要改改
- 疫苗|第三针开打！这些人可打疫苗加强针
- 疫苗|紧急告知！这些人不能打新冠疫苗！
- 疫苗|国产宫颈癌疫苗和进口疫苗哪个更好？妇科医生告诉你答案！
- 预防艾滋病|艾滋病患者福音要来了？mRNA疫苗开始临床试验，治愈或不再是幻想
- 癌症|得癌症的人还能再搞对象结婚吗？医生的答案来了……
- 癌症|癌症的影子投进我们四年的婚姻
- 医院|大便出现这3种情况，别忽视，有可能是癌症的前兆！
- 疫情|详细数据来了！这轮疫情中新冠疫苗已在起作用